INS and metabolic syndrome: In another randomized, controlled trial in men with metabolic syndrome, nasoduodenal tube-facilitated Allo-FMT derived from lean individuals was associated with improved insulin sensitivity and increased microbial diversity compared to individuals who received Auto-FMT after 6 weeks of intervention [134].